These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 8510103)

  • 1. Synthesis and tissue distribution of (m-[125I]iodobenzyl)trozamicol ([125I]MIBT): potential radioligand for mapping central cholinergic innervation.
    Efange SM; Michelson RH; Khare AB; Thomas JR
    J Med Chem; 1993 Jun; 36(12):1754-60. PubMed ID: 8510103
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Measurement of functional cholinergic innervation in rat heart with a novel vesamicol receptor ligand.
    Coffeen PR; Efange SM; Haidet GC; McKnite S; Langason RB; Khare AB; Pennington J; Lurie KG
    Nucl Med Biol; 1996 Oct; 23(7):923-6. PubMed ID: 8971861
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The vesamicol receptor ligand (+)-meta-[125I]iodobenzyltrozamicol [(+)-[125I]-MIBT] reveals blunting of the striatal cholinergic response to dopamine D2 receptor blockade in the 6-hydroxydopamine (6-OHDA)-lesioned rat: possible implications for Parkinson's disease.
    Efange SM; Langason RB; Khare AB; Low WC
    Life Sci; 1996; 58(16):1367-74. PubMed ID: 8614294
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Age-related diminution of dopamine antagonist-stimulated vesamicol receptor binding.
    Efange SM; Langason RB; Khare AB
    J Nucl Med; 1996 Jul; 37(7):1192-7. PubMed ID: 8965197
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vesamicol receptor mapping of brain cholinergic neurons with radioiodine-labeled positional isomers of benzovesamicol.
    Jung YW; Frey KA; Mulholland GK; del Rosario R; Sherman PS; Raffel DM; Van Dort ME; Kuhl DE; Gildersleeve DL; Wieland DM
    J Med Chem; 1996 Aug; 39(17):3331-42. PubMed ID: 8765517
    [TBL] [Abstract][Full Text] [Related]  

  • 6. p-[18F]fluorobenzyltrozamicol ([18F]FBT): molecular decomposition- reconstitution approach to vesamicol receptor radioligands for positron emission tomography.
    Efange SM; Mach RH; Khare A; Michelson RH; Nowak PA; Evora PH
    Appl Radiat Isot; 1994 Apr; 45(4):465-72. PubMed ID: 8186771
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of a novel vesamicol receptor ligand, m-(iodobenzyl)trozamicol, on the canine isolated, blood-perfused atrioventricular node preparation.
    Sugiyama A; Lurie KG; Efange SMN ; Takahara A; Takehana S; Haghimoto K
    Jpn J Pharmacol; 2000 Feb; 82(2):150-4. PubMed ID: 10877534
    [TBL] [Abstract][Full Text] [Related]  

  • 8. N-(3-Iodophenyl)trozamicol (IPHT) and related inhibitors of vesicular acetylcholine transport: synthesis and preliminary biological characterization.
    Khare AB; Langason RB; Parsons SM; Mach RH; Efange SM
    Nucl Med Biol; 1999 Aug; 26(6):609-17. PubMed ID: 10587098
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Radioiodinated 2-hydroxy-3-(4-iodophenyl)-1-(4-phenylpiperidinyl)propane: potential radiotracer for mapping central cholinergic innervation in vitro.
    Efange SM; Dutta AK; Michelson RH; Kung HF; Thomas JR; Billings J; Boudreau RJ
    Int J Rad Appl Instrum B; 1992 Apr; 19(3):337-48. PubMed ID: 1629023
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacological characterization of the vesamicol analogue (+)-[(125)I]MIBT in primate brain.
    Staley JK; Mash DC; Parsons SM; Khare AB; Efange SM
    Eur J Pharmacol; 1997 Nov; 338(2):159-69. PubMed ID: 9455998
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Radioiodinated (-)-2-[4-(3-iodophenyl) piperidino] cyclohexanol: a potential radioligand for mapping presynaptic cholinergic neurons.
    Shiba K; Mori H; Matsuda H; Ichikawa A; Tonami N
    Nucl Med Commun; 1996 Jun; 17(6):485-92. PubMed ID: 8822746
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative tissue distribution of conformationally restricted radioiodinated vesamicol receptor ligands.
    Efange SM; Khare AB; Langason RB
    Nucl Med Biol; 1995 May; 22(4):437-44. PubMed ID: 7550019
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Direct cardiac effects of a novel vesamicol receptor ligand, m-iodobenzyl-trozamicol, assessed in the canine isolated, blood-perfused heart preparations.
    Sugiyama A; Lurie KG; Efange SM; Takehana S; Hashimoto K
    J Cardiovasc Pharmacol; 1999 Dec; 34(6):843-7. PubMed ID: 10598128
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and biological characterization of stable and radioiodinated (+/-)-trans-2-hydroxy-3-P[4-(3-iodophenyl)piperidyl]-1,2,3,4-tetrahydronaphthalene (3'-IBVM).
    Efange SM; von Hohenberg K ; Khare AB; Tu Z; Mach RH; Parsons SM
    Nucl Med Biol; 2000 Nov; 27(8):749-55. PubMed ID: 11150707
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vivo characterization of radioiodinated 2-(4-phenylpiperidino)cyclohexanol (vesamicol) analogs: potential radioligand for mapping presynaptic cholinergic neurons.
    Shiba K; Mori H; Matsuda H; Tsuji S; Tonami N; Hisada K
    Nucl Med Biol; 1995 Aug; 22(6):823-8. PubMed ID: 8535345
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis, in vitro validation and in vivo pharmacokinetics of [125I]N-[2-(4-iodophenyl)ethyl]-N-methyl-2-(1-piperidinyl) ethylamine: a high-affinity ligand for imaging sigma receptor positive tumors.
    John CS; Gulden ME; Vilner BJ; Bowen WD
    Nucl Med Biol; 1996 Aug; 23(6):761-6. PubMed ID: 8940718
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [3H]vesamicol binding in brain: autoradiographic distribution, pharmacology, and effects of cholinergic lesions.
    Altar CA; Marien MR
    Synapse; 1988; 2(5):486-93. PubMed ID: 2973145
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vivo [125I]-iodobenzovesamicol binding reflects cortical cholinergic deficiency induced by specific immunolesion of rat basal forebrain cholinergic system.
    Sorger D; Schliebs R; Kämpfer I; Rossner S; Heinicke J; Dannenberg C; Georgi P
    Nucl Med Biol; 2000 Jan; 27(1):23-31. PubMed ID: 10755642
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Distribution of S(-)-zacopride-insensitive [125I]R(+)-zacopride binding sites in the rat brain and peripheral tissues.
    Ge J; Barnes JM; Towers P; Barnes NM
    Eur J Pharmacol; 1997 Aug; 332(3):307-12. PubMed ID: 9300265
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis, in vitro binding, and tissue distribution of radioiodinated 2-[125I]N-(N-benzylpiperidin-4-yl)-2-iodo benzamide, 2-[125I]BP: a potential sigma receptor marker for human prostate tumors.
    John CS; Gulden ME; Li J; Bowen WD; McAfee JG; Thakur ML
    Nucl Med Biol; 1998 Apr; 25(3):189-94. PubMed ID: 9620622
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.